| 000 | 01116 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250511192708.0 | ||
| 264 | 0 | _c19920522 | |
| 008 | 199205s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/0959-8049(92)90425-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWiedemann, L M | |
| 245 | 0 | 0 |
_aHow are cancer associated genes activated or inactivated? _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _c1992 |
||
| 300 |
_a248-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 |
_aGenes, Tumor Suppressor _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aOncogenes |
| 650 | 0 | 4 | _aProto-Oncogene Mas |
| 650 | 0 | 4 |
_aProto-Oncogenes _xgenetics |
| 650 | 0 | 4 | _aTranslocation, Genetic |
| 700 | 1 | _aMorgan, G J | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 28 _gno. 1 _gp. 248-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0959-8049(92)90425-2 _zAvailable from publisher's website |
| 999 |
_c1574158 _d1574158 |
||